Stephanie Abrams
Pediatric Gastroenterology · Houston, TXNPI 1427160076
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $82,788 of the $93,635 with a category attached, or 88.4%. Alcresta Therapeutics, Inc. accounts for 64.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $27,452 and has fallen 53.5% since, to $12,777 in 2025. Among pediatric gastroenterology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $761.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcresta Therapeutics, Inc.$60K
- AbbVie$33K
- Sanofi$325
- Regeneron Healthcare Solutions, Inc.$105
- Takeda Pharmaceuticals U.S.A., Inc.$86
- Rhythm Pharmaceuticals, Inc.$65
- plus $288 from 11 others
Across 8 payments — averaging $271.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vivus LLC$1K
- AbbVie$750
What the payments were for
- Consulting fees$2,5003%
- Speaking & faculty fees$82,78888%
- Travel & lodging$5,5886%
- Food & beverage$2,6883%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcresta Therapeutics, Inc. | 58 | $60,015 |
| AbbVie(2 entities) | 29 | $32,751 |
| Sanofi | 11 | $325 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Rhythm Pharmaceuticals, Inc. | 3 | $65 |
| QOL Medical, LLC | 2 | $57 |
| Acadia Pharmaceuticals Inc | 2 | $41 |
| Boston Scientific | 1 | $41 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Chiesi USA, Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $22 |
| Albireo Pharma, Inc. | 1 | $18 |
| Capsovision, Inc. | 1 | $18 |
| Covidien LP | 1 | $16 |
| Vertex | 1 | $14 |
| Travere Therapeutics, Inc. | 3 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$93,635 in reported general payments places this provider in the 95th percentile of 159 pediatric gastroenterology providers in Texas.
Other pediatric gastroenterology in Houston
- Wenly RuanHouston$155K
- Ruben QuirosHouston$32K
- Daniel LeungHouston$31K
- Faith IhekweazuHouston$21K
- Bruno ChumpitaziHouston$18K
- Kathleen MotilHouston$17K
- Sanjiv HarpavatHouston$12K
- Stanton MalowitzHouston$2K
- Naveen MittalDallas$182K
- Amal AqulDallas$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.